The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

CEVAC MASS L lyophilisate for oculonasal suspension for chicken

. Lyophilisate for suspension

CEVA-Phylaxia Veterinary Biologicals Co. LtdVPA10463/004/001

Main Information

Trade NameCEVAC MASS L lyophilisate for oculonasal suspension for chicken
Active SubstancesLive attenuated infectious bronchitis disease virus, Massachusetts type, strain B48
Dosage FormLyophilisate for suspension
Licence HolderCEVA-Phylaxia Veterinary Biologicals Co. Ltd
Licence NumberVPA10463/004/001

Group Information

ATC CodeQI01AD07 avian infectious bronchitis virus
Therapeutic ClassImmunological - Live Vaccine


Licence Issued20/05/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back